mri of rectal cancer - puzzlepix · mri of rectal cancer dr damian tolan consultant...
TRANSCRIPT
MRI of Rectal CancerDr Damian Tolan
Consultant Gastrointestinal RadiologistLeeds Teaching Hospitals
Hungarian Congress of Radiology June 2016
1. What are we doing this scan for?
2. How to get a good scan
3. What should we say?
How I report MRI of rectal cancer
1. Radiologists are now key members of a BIG multidisciplinary team.
2. There are a lot of people to cater for…
What are we doing this for?
We need to cater for a lot of tastes� Does the patient need an operation?
� What type of operation?
� Do they need Preoperative treatment?
� Radiotherapy
� Chemotherapy
� both?
What are we doing this for?
We are like Chefs
� We must use only the best ingredients
� We should always produce digestible food
� The meal should be the same every time…which ever chef is cooking!
What is our job?
� Good quality MRI is essential to a good report
� The key components…� Phased array body/pelvis coil
� Adequate coverage
� High resolution/small field of view
� Thin slices (3mm)
� Angulation
The best ingredients
Brown Radiology 2003
Orthogonal and perpendicular to the tumour
� Why?
TO ANSWER THE KEY QUESTIONS
� How far has tumour penetrated?
� What is the relationship to the circumferential resection margin?
Angulation
Imaging planes - orientation
• Inclined axial sphincter invasion
Angulation - low
nb. white = mucinous = worse prognosis
Imaging planes - orientation
• Inclined coronal relationship to levator
Angulation - low
nb. white = mucinous = worse prognosis
Imaging planes – orientation
• Sagittal for planning axial – relation to mesorectum
Angulation - upper
Remnant of embrylogical hindgut mesentery
Contains:
� Rectum
� Fat
� Lymph nodes
� Vessels
This is resected complete in a Total MesorectalExcision (TME)
This boundary becomes the Circumferential Resection Margin (CRM)
Mesorectal fascia?
TNM stage of the tumour predicts outcome
TNM stratifies benefit from neoadjuvanttherapy
What is the relevance of staging?
T1 - tumour invasion into submucosa
Muscularis propria not invaded
T staging
Cancer within large pedunculated tubulovillous adenoma
T1 - tumour invasion into submucosa
�These patients may be offered local resection
(Transanal Endoscopic MicroSurgery – TEMS)
T staging
Muscularis propria
Focus of invasive cancer in TVA
MucosaSubmucosa
T2 – tumour invasion into muscularis propria
Muscularis invaded (not beyond)
T staging
Tumour cannot be distinguished from muscularis
T2 – tumour invasion into muscularis propria
�Usually straight to surgery
T staging
Tumour cannot be distinguished from muscularis
T stagingT3- invasion beyond muscularis propria
Mesorectal
fascia invaded by
tumour
Muscularis completely replaced
T3 tumours – ‘the GOOD’T staging
T3b 1-5mm
T3a<1mm
Muscularis propria
MERCURY study group Radiology 2007
T3 tumours – ‘the GOOD’� May go straight to surgery� Short course radiotherapy if other
adverse features � E.g. positive nodes or extramural vascular
invasion
T staging
MERCURY study group Radiology 2007
T3 tumours – ‘the BAD’T staging
T3(any) & threatened CRM
T3c 5-15mm
T3d>15mm
1mm or less
(tumour to mesorectal
fascia)
Mesorectal fascia
MERCURY study group Radiology 2007
Mesorectal Fascia and CRM
Tumour involving or within 1mm of the MRE is a strong predictor for local recurrence
If you see it you MUST say it! Tumour in contact with CRM
12-1 o’clock
T3 tumours – ‘the BAD’� Usually offered
Chemoradiotherapy beforesurgery
T staging
MERCURY study group Radiology 2007
T4 - invasion of adjacent structures
� Peritoneum
� Viscera
� Pelvic sidewall
� Sphincter / pelvic
floor
T staging
T4 - invasion of adjacent structures
� Given neoadjuvantCRT
� Likely positive resection margin unless it is resected
(E.g. an organ or peritoneal resection)
T staging
Nodal disease� Size not a useful discriminator� Shape important -irregular border� Internal architecture -mixed signal
intensity
N stage
Brown et al Radiology 2003
Nodal disease� When either or both are present (even
in small nodes)� Sensitivity 85%� Specificity 97%for malignancy
N stage
Brown et al Radiology 2003
Mesorectal nodes� Relationship to CRM not so important
� Positive nodes within 1mm of CRM not strong predictor of local recurrence (vs. direct tumour spread)
� Main risk is 4 or more nodes (N2)
N stage
Shihab et al Br J Surg 2010
Pelvic side wall nodes� Not in a usual surgical resection� Can be targeted with a ‘boost’ of
radiotherapy � Difficult to identify when
laparoscopic resection (or even open)
� Not an independent prognostic factor (cf primary tumour features)
N stage
MERCURY Study Group Br J Surg 2011
Don’t ‘over call’ nodes� only call those that are definitely
abnormal� +ve nodes at the CRM do not have
the same implication as direct tumour
N stage
Extramural vascular invasion� Present in up to 50% specimens� Poor prognostic factor� Increases risk of distant
metastasis and pelvic side wall nodal disease
V stage
Smith et al AJR 2008
Mucinous differentiation = white tumourconsider adding T1 axial (helps with spotting nodes
Other features
Mucinous differentiation = white tumourconsider adding T1 axial (helps with spotting nodes)
Other features
MERCURY study group Radiology 2007
Reporting Proforma:Should we all be saying the same thing?WE WILL BE SOON…
� Know how TNM relates to patient care� Prepare well (angulation & resolution)� Don’t leave any ingredients out
(T, N, V, CRM status, M-)� Use the same recipe EVERY TIME
Conclusion
To my all my Colorectal MDT colleaguesColorectal Surgery: Sagar, Jayne, Botterill, Burke, Saunders, Baker, Hance, Maslekar, RiyadClinical Oncology: Sebag-Montefiore, Radhakrishna, Casanova, CooperMedical Oncology: Seymour, Anthoney, Swinson, HookPathology: Scott, Rotimi, West
Especially to my fellow Chefs (Radiologists)!Rachel Hyland, Hannah Lambie, Tom Kaye, Elen Thomson
Finally, thanks…